Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation
Abstract
:1. Introduction
2. Materials and Methods
2.1. Reagents
2.2. Cells
2.3. Cell Treatments
2.4. Mice Treatments
2.5. Immunoblot Analysis
2.6. Quantitative qRT-PCR
2.7. Iron Quantification
2.8. Ferritin Iron Determination
2.9. ELISA for Mouse l-Ferritin
2.10. Statistics
3. Results
3.1. Cell Treatments with the Digested Iron Preparations
3.2. Oral Iron Treatments of Mice with Normal Iron Status
3.3. Oral Iron Treatments of Mice with Iron Deficiency Anemia
4. Discussion
Supplementary Materials
Author Contributions
Funding
Conflicts of Interest
References
- Kassebaum, N.J.; Jasrasaria, R.; Naghavi, M.; Wulf, S.K.; Johns, N.; Lozano, R.; Regan, M.; Weatherall, D.; Chou, D.P.; Eisele, T.P.; et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2013, 123, 615–624. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tolkien, Z.; Stecher, L.; Mander, A.P.; Pereira, D.I.; Powell, J.J. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: A systematic review and meta-analysis. PLoS ONE 2015, 10, e0117383. [Google Scholar] [CrossRef] [PubMed]
- Girelli, D.; Ugolini, S.; Busti, F.; Marchi, G.; Castagna, A. Modern iron replacement therapy: Clinical and pathophysiological insights. Int. J. Hematol. 2018, 107, 16–30. [Google Scholar] [CrossRef] [PubMed]
- Toblli, J.E.; Cao, G.; Olivieri, L.; Angerosa, M. Comparative study of gastrointestinal tract and liver toxicity of ferrous sulfate, iron amino chelate and iron polymaltose complex in normal rats. Pharmacology 2008, 82, 127–137. [Google Scholar] [CrossRef] [PubMed]
- Gulec, S.; Anderson, G.J.; Collins, J.F. Mechanistic and regulatory aspects of intestinal iron absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 307, 397–409. [Google Scholar] [CrossRef] [PubMed]
- Zimmermann, M.B.; Chassard, C.; Rohner, F.; N’goran, E.K.; Nindjin, C.; Dostal, A.; Utzinger, J.; Ghattas, H.; Lacroix, C.; Hurrell, R.F. The effects of iron fortification on the gut microbiota in african children: A randomized controlled trial in cote d’ivoire. Am. J. Clin. Nutr. 2010, 92, 1406–1415. [Google Scholar] [CrossRef] [PubMed]
- Jaeggi, T.; Kortman, G.A.; Moretti, D.; Chassard, C.; Holding, P.; Dostal, A.; Boekhorst, J.; Timmerman, H.M.; Swinkels, D.W.; Tjalsma, H.; et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in kenyan infants. Gut 2014, 64, 731–742. [Google Scholar] [CrossRef] [PubMed]
- Lane, D.J.; Merlot, A.M.; Huang, M.L.; Bae, D.H.; Jansson, P.J.; Sahni, S.; Kalinowski, D.S.; Richardson, D.R. Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 2015, 1853, 1130–1144. [Google Scholar] [CrossRef] [PubMed]
- Lynch, S. Influence of infection/inflammation, thalassemia and nutritional status on iron absorption. Int. J. Vitam. Nutr. Res. 2007, 77, 217–223. [Google Scholar] [CrossRef] [PubMed]
- Weiss, G.; Gordeuk, V.R. Benefits and risks of iron therapy for chronic anaemias. Eur. J. Clin. Invest. 2005, 35, 36–45. [Google Scholar] [CrossRef] [PubMed]
- Fabiano, A.; Brilli, E.; Fogli, S.; Beconcini, D.; Carpi, S.; Tarantino, G.; Zambito, Y. Sucrosomial® iron absorption studied by in vitro and ex-vivo models. Eur. J. Pharm. Sci. 2018, 111, 425–431. [Google Scholar] [CrossRef] [PubMed]
- Elli, L.; Ferretti, F.; Branchi, F.; Tomba, C.; Lombardo, V.; Scricciolo, A.; Doneda, L.; Roncoroni, L. Sucrosomial iron supplementation in anemic patients with celiac disease not tolerating oral ferrous sulfate: A prospective study. Nutrients 2018, 10, 330. [Google Scholar] [CrossRef] [PubMed]
- Ciudin, A.; Simó-Servat, O.; Balibrea, J.M.; Vilallonga, R.; Hernandez, C.; Simó, R.; Mesa, J. Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The bari-fer study. Endocrinol. Diabetes Nutr. 2018, 65, 17–20. [Google Scholar] [CrossRef] [PubMed]
- Giordano, G.; Mondello, P.; Tambaro, R.; Perrotta, N.; D’Amico, F.; D’Aveta, A.; Berardi, G.; Carabellese, B.; Patriarca, A.; Corbi, G.M.; et al. Biosimilar epoetin α is as effective as originator epoetin-α plus liposomal iron (sideral®), vitamin b12 and folates in patients with refractory anemia: A retrospective real-life approach. Mol. Clin. Oncol. 2015, 3, 781–784. [Google Scholar] [CrossRef] [PubMed]
- Barni, S.; Gascòn, P.; Petrelli, F.; García-Erce, J.A.; Pedrazzoli, P.; Rosti, G.; Giordano, G.; Mafodda, A.; Múñoz, M. Position paper on management of iron deficiency in adult cancer patients. Expert Rev. Hematol. 2017, 10, 685–695. [Google Scholar] [CrossRef] [PubMed]
- Mafodda, A.; Giuffrida, D.; Prestifilippo, A.; Azzarello, D.; Giannicola, R.; Mare, M.; Maisano, R. Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: A pilot study. Support. Care Cancer 2017, 25, 2779–2786. [Google Scholar] [CrossRef] [PubMed]
- Pisani, A.; Riccio, E.; Sabbatini, M.; Andreucci, M.; Del Rio, A.; Visciano, B. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in ckd patients: A randomized trial. Nephrol. Dial. Transplant. 2015, 30, 645–652. [Google Scholar] [CrossRef] [PubMed]
- Capra, A.P.; Ferro, E.; Cannavo, L.; La Rosa, M.A.; Zirilli, G. A child with severe iron-deficiency anemia and a complex tmprss6 genotype. Hematology 2017, 22, 559–564. [Google Scholar] [CrossRef] [PubMed]
- Castagna, A.; Campostrini, N.; Zaninotto, F.; Girelli, D. Hepcidin assay in serum by seldi-tof-ms and other approaches. J. Proteom. 2010, 73, 527–536. [Google Scholar] [CrossRef] [PubMed]
- Poli, M.; Asperti, M.; Naggi, A.; Campostrini, N.; Girelli, D.; Corbella, M.; Benzi, M.; Besson-Fournier, C.; Coppin, H.; Maccarinelli, F.; et al. Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. Blood 2014, 123, 1564–1573. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Girelli, D.; Nemeth, E.; Swinkels, D.W. Hepcidin in the diagnosis of iron disorders. Blood 2016, 127, 2809–2813. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Udali, S.; Castagna, A.; Corbella, M.; Ruzzenente, A.; Moruzzi, S.; Mazzi, F.; Campagnaro, T.; Santis, D.; Franceschi, A.; Pattini, P.; et al. Hepcidin and dna promoter methylation in hepatocellular carcinoma. Eur. J. Clin. Investig. 2018, 48, e12870. [Google Scholar] [CrossRef] [PubMed]
- Roetto, A.; Di Cunto, F.; Pellegrino, R.; Hirsch, E.; Azzolino, O.; Bondi, A.; Defilippi, I.; Carturan, S.; Miniscalco, B.; Riondato, F.; et al. Comparison of 3 tfr2-deficient murine models suggests distinct functions for tfr2-alpha and tfr2-beta isoforms in different tissues. Blood 2010, 115, 3382–3389. [Google Scholar] [CrossRef] [PubMed]
- Hirsh, M.; Konijn, A.M.; Iancu, T.C. Acquisition, storage and release of iron by cultured human hepatoma cells. J. Hepatol. 2002, 36, 30–38. [Google Scholar] [CrossRef]
- Nemeth, E.; Ganz, T. Regulation of iron metabolism by hepcidin. Annu. Rev. Nutr. 2006, 26, 323–342. [Google Scholar] [CrossRef] [PubMed]
- Ketteler, M.; Block, G.A.; Evenepoel, P.; Fukagawa, M.; Herzog, C.A.; McCann, L.; Moe, S.M.; Shroff, R.; Tonelli, M.A.; Toussaint, N.D.; et al. Executive summary of the 2017 kdigo chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: What’s changed and why it matters. Kidney Int. 2017, 92, 26–36. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Asperti, M.; Gryzik, M.; Brilli, E.; Castagna, A.; Corbella, M.; Gottardo, R.; Girelli, D.; Tarantino, G.; Arosio, P.; Poli, M. Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation. Nutrients 2018, 10, 1349. https://doi.org/10.3390/nu10101349
Asperti M, Gryzik M, Brilli E, Castagna A, Corbella M, Gottardo R, Girelli D, Tarantino G, Arosio P, Poli M. Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation. Nutrients. 2018; 10(10):1349. https://doi.org/10.3390/nu10101349
Chicago/Turabian StyleAsperti, Michela, Magdalena Gryzik, Elisa Brilli, Annalisa Castagna, Michela Corbella, Rossella Gottardo, Domenico Girelli, Germano Tarantino, Paolo Arosio, and Maura Poli. 2018. "Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation" Nutrients 10, no. 10: 1349. https://doi.org/10.3390/nu10101349